Recently visited unit

Optional shares

name	Price (yuan)	Rise and fall
The following are popular stocks

Please check the self selected shares first Sign in

name	Price (yuan)	Rise and fall

Management of self selected shares

^_^ sign out

join remind View in APP

Open medical treatment (300633.SZ)

Questioning stocks

@change@

@changeP@

@now@

Limit: @ up_limit@

Limit: @ down_limit@

Suspension

@date@ @time@

Temporary suspension

Today:	@open@	Volume:	@volume@	Amplitude:	@swing@
Maximum:	@high@	Turnover:	@amount@	turnover rate:	@turnover@
Minimum:	@low@	Total Market Value:	@fixTotalShare@	P/B ratio:	@pb@
Received yesterday:	@preClose@	Circulation value:	@cvs@	P/E ratio^TTM ：	@pe@
Total share capital:	@zgb@	Circulating shares:	@ltgb@

Information mine:

The browser version is too low to view the multi null inversion

Your browser version is too low to view empty data. It is recommended to use IE10 (including) above Firefox 、 Google

Trend comparison:

market index

Shanghai Stock Exchange Index

Shenzhen Stock Index

CSI 300

compare

Time-sharing

Day K

Week K

Month K

K line

Reinstatement K line

Technical drawings

Trend comparison:

market index

Shanghai Stock Exchange Index

Shenzhen Stock Index

CSI 300

compare

Also concerned:

5th gear disc opening

Live broadcast of famous teachers

Commission ratio -- Abandonment --
Selling ⑤	--	--
Sell ④	--	--
Selling ③	--	--
Sell ②	--	--
Selling ①	--	--
deal	--
Buy ①	--	--
Buy ②	--	--
Buy ③	--	--
Buy ④	--	--
Buy ⑤	--	--
Outer disc -- Inner disc --

In case of a key big order, the main force may**

Quickly use level2 to view details>

Pen by pen

Large order

Price sharing

Time-sharing

time	Price (yuan)	Measurement (hand)	nature

time	Price (yuan)	Measurement (hand)	nature

Transaction price (yuan)	Trading volume (hand)	Proportion (%)

time	Transaction price (yuan)	Trading volume (hand)

Scan code subscription

Investment research report

Questioning stocks

Live broadcast of stock market

Product entry: Sina Finance APP - Stocks - Investment Research Report

Product entrance: Sina Finance APP - stock - free question

money flow

Main compass Indicator description

Main and retail investors' capital flow
	Main buy	Main sales	Purchase by retail investors	Retail sales
Amount (10000 yuan)	@mainIn@	@mainOut@	@retailIn@	@retailOut@
proportion	@mainInP@	@mainOutP@	@retailInP@	@retailOutP@

Loose bill

Small order

Large order

Extra large order

Net inflow of classified funds
	Loose bill	Small order	Large order	Extra large order
Net inflow (10000 yuan)	@r3_r_in@	@r2_r_in@	@r1_r_in@	@r0_r_in@
Proportion in the flow board	@r3_p_svs@	@r2_p_svs@	@r1_p_svs@	@r0_p_svs@
Proportion in turnover rate	@r3_p_turnover@	@r2_p_turnover@	@r1_p_turnover@	@r0_p_turnover@

research report

Company research

Industry research

Big V view

Open medical stock exchange

title click reply Final reply

#Open a medical discussion on "EU starts the market of medical equipment procurement to China" one thousand four hundred and ninety zero 04-24 17:06
[Open medical service and Huizhen Surgical Innovation Experience Center in Shanghai one thousand three hundred and thirty zero 04-16 17:08
[Open medical treatment: the planned income of minimally invasive surgery business line this year is the same as one thousand one hundred and forty-one zero 04-12 12:13
The opening price of medical service rose by 3.79% one thousand three hundred and twenty-four zero 04-12 09:26
[Medical treatment: net profit attributable to parent increased by 22% year on year in 2023 one thousand one hundred and eleven zero 04-11 19:12
The opening price of medical service rose 3.17% one thousand nine hundred and fifty-nine zero 03-14 09:26
[Open medical treatment: the company has a large market expansion space for soft mirror products three thousand three hundred and sixty-six zero 01-12 12:22
[Minsheng Medicine] Philips is supported by the Gates Foundation, and AI endows four thousand one hundred and thirty-three zero 11-10 20:56

[Medical treatment: 60 million to 120 million yuan three thousand seven hundred and eighty-five zero 11-07 18:16
[226 companies were surveyed by institutions three thousand seven hundred and seventy-four zero 10-30 08:29
[Opening medical treatment: the actual controller proposed 60 million yuan for the company- four thousand and seventeen zero 10-29 20:17
[Open medical treatment: endoscopy still maintained a high growth rate in the third quarter] four thousand and eighty-nine zero 10-27 13:04
[Issuance of medical treatment: commitment of the controlling shareholder and its persons acting in concert 1 three thousand seven hundred and seventy-five zero 10-26 17:10
[Medical treatment: controlling shareholders, directors, senior managers four thousand one hundred and eight zero 10-26 16:56
[Medical treatment: net profit attributable to parent company in the first half of the year was 273 million yuan six thousand six hundred and fifty-one zero 08-22 22:12
[Opening a medical service: it is not obvious that medical anti-corruption will affect business five thousand and eight hundred zero 08-14 09:14

Company research

Hot data

Adjacent ranking

Top 10 in the industry

Financial ratios

Adjacent ranking

Top 10 in the industry

Investment rating of research institutions

In the last 60 days Three research reports issued medical (sz300633) rating, and the comprehensive rating is as follows:

Hot columns

Industry comparison

name	Price (yuan)

expand all Pack All

Investment instruments

Market trend

Distribution

Equity shareholders

Company announcement

financial data

Major events

Company Profile

corporate name:

Shenzhen Kaifa Biomedical Technology Co., Ltd

Main business:

Independent research, development, production and sales of medical diagnosis and treatment equipment.

Telephone: 0755-26722890

Fax: 0755-26722850

Date of establishment: 2002-09-27

Listing date: 2017-04-06

Legal representative: Chen Zhiqiang

general manager: Wu Kunxiang

Registered capital: 432712000 yuan

Issue price: 5.230 yuan

Latest total share capital: 432712405 shares

Latest outstanding shares: 257144415 shares

Segment: Shenzhen A-share GEM Shanghai and Shenzhen A-share Shenzhen Composite Index Shenzhen Stock Connect Shenzhen Stock Connect Shenzhen Stock Index GEM Pharmaceutical Biology medical apparatus and instruments Pharmaceutical Biology Medical equipment

Financial summary

2024-03

2023-12

2023-09

2023-06

2023-03

Earnings per share	0.2316 yuan	1.0552 yuan	0.7445 yuan	0.6341 yuan	0.3215 yuan
net asset value per share	7.5283 yuan	7.3051 yuan	7.1039 yuan	RMB 6.9663	6.8029 yuan
Net operating cash flow per share	-0.0659 yuan	1.1366 yuan	0.5600 yuan	0.3503 yuan	0.1121 yuan
Return on net assets	3.08%	14.45%	10.48%	9.10%	4.73%
Undistributed profit per share	3.5346 yuan	3.3175 yuan	3.1233 yuan	3.0128 yuan	2.8803 yuan
Capital reserve per share	2.6760 yuan	2.5984 yuan	2.5641 yuan	2.5490 yuan	2.5242 yuan

Date of announcement	Allocation scheme
2024-05-22	10 pai 3.2 yuan
2023-06-01	10 pies 1.8 yuan
2022-07-08	RMB 1.25 for 10 pies
2020-07-04	10 Pies RMB 0.26
2019-06-05	10 pie 0.65 yuan

Circulation shareholders

2024-03

2023-12

2023-11

Name of shareholders	Shareholding (%)	Increase or decrease
Chen Zhiqiang	thirty-seven point five two seven	Unchanged
Wu Kunxiang	thirty-seven point five two seven	Unchanged
Huang Yibo	seven point eight three zero	Unchanged
Zhou Wenping	five point eight six four	Unchanged
HKSCC has	five point zero seven six	Overweight
Li Hao	three point zero zero four	Unchanged
Bank of China shares have	two point four five nine	reduce one's shares in a listed company
Huitianfu Fund Management	two point three three nine	Unchanged
Industrial and Commercial Bank of China shares	one point nine nine six	New progress
China Construction Bank Co., Ltd	one point nine four six	Unchanged

Name of shareholders	Shareholding (%)	Increase or decrease
Chen Zhiqiang	thirty-seven point five two seven	Overweight
Wu Kunxiang	thirty-seven point five two seven	Overweight
Huang Yibo	seven point eight three zero	Overweight
Zhou Wenping	five point eight six four	New progress
HKSCC has	three point three one zero	Overweight
Li Hao	three point zero zero four	New progress
Bank of China shares have	two point four nine zero	reduce one's shares in a listed company
Huitianfu Fund Management	two point three three nine	Unchanged
China Construction Bank Co., Ltd	one point nine four six	Overweight
Liu Yingfang	one point eight seven seven	Unchanged

Name of shareholders	Shareholding (%)	Increase or decrease
Chen Zhiqiang	nine point three eight two	reduce one's shares in a listed company
Wu Kunxiang	nine point three eight two	reduce one's shares in a listed company
HKSCC has	two point seven six seven	Overweight
Bank of China shares have	two point six four four	Overweight
Huitianfu Fund Management	two point three three nine	Unchanged
Industrial and Commercial Bank of China shares	one point nine six zero	New progress
Huang Yibo	one point nine five eight	reduce one's shares in a listed company
Liu Yingfang	one point eight seven seven	Unchanged
China Construction Bank Co., Ltd	one point eight five six	Unchanged
China Construction Bank Co., Ltd	one point five seven eight	New progress

user name:
Password:
	Record login status for one month
	Sign in Retrieve password Login Help Not yet a member of Sina? New User Registration

Open medical treatment (300633.SZ)

Investment research report

Live broadcast of stock market

money flow

Company Information

research report

Big V view

Company No

Open medical stock exchange

Company research

Hot data

Financial ratios

Investment rating of research institutions

Hot columns

Industry comparison

Investment instruments

Market trend

Company information

Distribution

Equity shareholders

Company announcement

financial data

Major events

Company Profile

Financial summary

Dividend distribution

Circulation shareholders

Shareholding ratio of circulating shareholders